Opportunity Information: Apply for HT942526OCRPCTA
The DoW Ovarian Cancer, Clinical Trial Award (Funding Opportunity Number HT942526OCRPCTA) is a discretionary U.S. Department of the Army grant opportunity administered through USAMRAA under the Ovarian Cancer Research Program (OCRP). Its purpose is to push ovarian cancer clinical trials forward quickly, with an emphasis on studies that could meaningfully change how ovarian cancer is treated or managed in real-world patient care. The core intent is practical impact: taking a credible idea that is ready for clinical testing and moving it into a trial that can generate actionable clinical evidence.
This award is specifically geared toward funding clinical trials across a wide range of stages and designs. Projects can be small and exploratory, such as proof-of-concept trials, pilot trials, first-in-human studies, or phase 0 efforts that establish feasibility, assess early signals, or generate data needed to design later-stage trials. At the same time, the program also allows for larger, more definitive trials aimed at determining efficacy in relevant ovarian cancer patient populations. In other words, the mechanism is not restricted to one trial phase; it supports a spectrum from early feasibility to larger-scale clinical evaluation, as long as the trial is positioned to influence the field.
The types of interventions and approaches that can be tested are broad and include promising products and pharmacologic agents, whether they are drugs or biologics, as well as medical devices, clinical guidance (such as care pathways or management strategies), and emerging technologies or novel clinical approaches. That breadth indicates the program is open to both therapeutic and management-focused trials, including studies that may optimize treatment selection, delivery, monitoring, or supportive care, provided the work is framed as a clinical trial and has clear relevance to ovarian cancer outcomes.
Eligibility is listed as unrestricted, which generally signals that a wide variety of applicant organizations may apply, rather than limiting submissions to a narrow set of institution types. The funding activity is categorized under Science and Technology and other Research and Development (CFDA 12.420). The opportunity is expected to make about two awards, and the posted original closing date is 2026-10-01. The award ceiling is not specified in the provided listing, so applicants would typically need to consult the full announcement package for budget limits, allowable costs, and any trial-specific requirements (for example, expectations around regulatory status, recruitment feasibility, statistical plans, data monitoring, and timelines).Apply for HT942526OCRPCTA
- The Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoW Ovarian Cancer, Clinical Trial Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on 2026-05-04.
- Applicants must submit their applications by 2026-10-01. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
DoW Ovarian Cancer, Clinical Trial Award (HT942526OCRPCTA) - FAQs
What is the DoW Ovarian Cancer, Clinical Trial Award?
The DoW Ovarian Cancer, Clinical Trial Award (Funding Opportunity Number HT942526OCRPCTA) is a discretionary U.S. Department of the Army grant opportunity administered through USAMRAA under the Ovarian Cancer Research Program (OCRP). It is designed specifically to fund ovarian cancer clinical trials.
What is the main purpose of this award?
The purpose is to move ovarian cancer clinical trials forward quickly, prioritizing studies that could meaningfully change how ovarian cancer is treated or managed in real-world patient care. The focus is on practical impact: taking a credible idea that is ready for clinical testing and generating actionable clinical evidence.
Is this opportunity only for a specific clinical trial phase?
No. The award supports a broad range of clinical trial stages and designs. It can fund early-stage efforts (for example, proof-of-concept, pilot, first-in-human, or phase 0 studies) as well as larger, more definitive trials aimed at determining efficacy in relevant ovarian cancer patient populations.
What kinds of early-stage trials are supported?
The program explicitly allows smaller and exploratory trials, including proof-of-concept trials, pilot trials, first-in-human studies, and phase 0 efforts. These may focus on feasibility, early signals of activity, or generating data needed to design later-stage trials.
Does the program support larger or more definitive clinical trials?
Yes. In addition to exploratory studies, the program allows larger trials intended to more definitively determine efficacy in ovarian cancer patient populations, as long as the trial is positioned to influence the field.
What types of interventions can be tested in supported trials?
The scope is broad. Trials may evaluate promising products and pharmacologic agents (including drugs and biologics), medical devices, clinical guidance (such as care pathways or management strategies), and emerging technologies or novel clinical approaches, as long as they are framed as a clinical trial and clearly relevant to ovarian cancer outcomes.
Are non-drug approaches eligible, such as care pathways or management strategies?
Yes. The opportunity includes clinical guidance approaches, such as care pathways or management strategies, and other management-focused trials that aim to improve treatment selection, delivery, monitoring, or supportive care, provided the project is a clinical trial with clear ovarian cancer relevance.
What does "practical impact" mean in the context of this award?
Based on the listing, the award prioritizes trials that can produce actionable evidence and are likely to meaningfully influence real-world ovarian cancer care. The intent is not just to explore an idea but to move a ready-for-testing concept into a clinical trial that can inform patient care.
Who is eligible to apply?
Eligibility is listed as unrestricted, which generally indicates that a wide variety of applicant organizations may apply rather than only a narrow set of institution types.
Which government offices or programs are associated with this funding opportunity?
This is a U.S. Department of the Army opportunity administered through USAMRAA under the Ovarian Cancer Research Program (OCRP).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is HT942526OCRPCTA.
What is the CFDA listing and funding activity category?
The funding activity is categorized under Science and Technology and other Research and Development, with CFDA 12.420.
How many awards are expected to be made?
The opportunity is expected to make about two awards.
What is the application deadline (closing date) for this opportunity?
The posted original closing date is 2026-10-01.
Is there an award ceiling or maximum budget amount listed?
No award ceiling is specified in the provided listing. To understand budget limits and cost rules, applicants would typically need to consult the full announcement package.
Where can applicants find details on allowable costs and trial requirements?
The provided listing indicates that details such as budget limits, allowable costs, and trial-specific requirements (for example, regulatory status expectations, recruitment feasibility, statistical plans, data monitoring, and timelines) would typically be found in the full announcement package.
What kinds of trial planning or operational elements may be important for applicants to address?
While the listing does not provide the full requirements, it flags common trial-specific expectations that may apply, such as regulatory status, recruitment feasibility, statistical plans, data monitoring, and timelines. The authoritative requirements would be in the full announcement package.
Does the opportunity emphasize speed or rapid trial start?
Yes. The stated purpose includes pushing ovarian cancer clinical trials forward quickly, with the goal of generating evidence that can impact clinical care.
Do projects have to be positioned to influence ovarian cancer care?
Yes. Across trial sizes and phases, the listing emphasizes that funded trials should be positioned to influence the field and meaningfully affect how ovarian cancer is treated or managed in real-world settings.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: NIJ FY25 Research and Evaluation on Youth Justice Topics
Previous opportunity: Leveling the Field for American Workers in U.S.-Mexico Trade
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HT942526OCRPCTA
Applicants also applied for:
Applicants who have applied for this opportunity (HT942526OCRPCTA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoW Breast Cancer, Breakthrough Award Level 3 Apply for HT942526BCRPBTA3 Funding Number: HT942526BCRPBTA3 Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW, Ovarian Cancer, Investigator-Initiated Research Award Apply for HT942526OCRPIIRA Funding Number: HT942526OCRPIIRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| NIJ FY25 Research and Evaluation on Drugs and Crime: Nexus with Firearms and Violence Apply for O NIJ 2025 172605 Funding Number: O NIJ 2025 172605 Agency: National Institute of Justice Category: Science and Technology and other Research and Development Funding Amount: $2,000,000 |
| DoW, Ovarian Cancer, Pilot Award Apply for HT942526OCRPPA Funding Number: HT942526OCRPPA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Breast Cancer, Era of Hope Scholar Award Apply for HT942526BCRPEOHS Funding Number: HT942526BCRPEOHS Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Breast Cancer, Transformative Breast Cancer Consortium Development Award Apply for HT942526BCRPTBCCDA Funding Number: HT942526BCRPTBCCDA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Breast Cancer, Transformative Breast Cancer Consortium Award Apply for HT942526BCRPTBCCA Funding Number: HT942526BCRPTBCCA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Spinal Cord Injury, Translational Research Award Apply for HT942526SCIRPTRA Funding Number: HT942526SCIRPTRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Hearing Restoration Focused Research Award Apply for HT942526HRRPFRA Funding Number: HT942526HRRPFRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Multiple Sclerosis Exploration-Hypothesis Development Award Apply for HT942526MSRPEHDA Funding Number: HT942526MSRPEHDA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Multiple Sclerosis Investigator-Initiated Research Award Apply for HT942526MSRPIIRA Funding Number: HT942526MSRPIIRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Multiple Sclerosis Early Investigator Research Award Apply for HT942526MSRPEIRA Funding Number: HT942526MSRPEIRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Spinal Cord Injury, Clinical Translation Research Award Apply for HT942526SCIRPCTRA Funding Number: HT942526SCIRPCTRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Spinal Cord Injury, Clinical Trial Award Apply for HT942526SCIRPCTA Funding Number: HT942526SCIRPCTA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Multiple Sclerosis Clinical Trial Award Apply for HT942526MSRPCTA Funding Number: HT942526MSRPCTA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Spinal Cord Injury, Investigator-Initiated Research Award Apply for HT942526SCIRPIIRA Funding Number: HT942526SCIRPIIRA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Lupus, Transformative Vision Award Apply for HT942526LRPTVA Funding Number: HT942526LRPTVA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Lupus, Idea Award Apply for HT942526LRPIA Funding Number: HT942526LRPIA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Lupus, Transformative Vision Development Award Apply for HT942526LRPTVDA Funding Number: HT942526LRPTVDA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Lupus, Impact Award Apply for HT942526LRPIPA Funding Number: HT942526LRPIPA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HT942526OCRPCTA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.